A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

NCT04372108 · clinicaltrials.gov ↗

RECRUITING

Status

1056

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease
Colitis, Ulcerative

Interventions

DRUG: Ustekinumab
DRUG: Other Biologic Therapies

Sponsor

Janssen Scientific Affairs, LLC